Presence of Candida and its associated factors in participants attending oral cancer screening in the lower northeastern area of Thailand

Table 2 Prevalence of Candida in participants according to oral lesions

Clinical diagnosis	Number of patients (n, %)		p value	Candida levels		p value^#
Clinical diagnosis	Low levels (< 1,000 CFU/ml)	High levels (≥ 1,000 CFU/ml)	p value	Mean score ± SD	Median (IQR)	p value^#
NOM (n = 132)	102 (24.8)	30 (18.1)	< 0.001*	1.73 ± 1.18	1 (1,2)^a	< 0.001*
OPMDs/OC (n = 165)	113 (27.5)	52 (31.3)		1.90 ± 1.36	2 (1,3)
Non-OPMDs/OC (n = 196)	155 (37.7)	41 (24.7)		1.53 ± 1.15	1 (1,2)^b
CSOC (n = 84)	41 (10.0)	43 (25.9)		2.39 ± 1.44	3 (1,4)^a,b
Total	411 (100)	166 (100)		1.82 ± 0.92	1 (1,3)

*Bold values denote statistical significance at the p < 0.05 level
Abbreviations: Normal oral mucosa; NOM, Oral potentially malignant disorders; OPMDs, Oral cancer; OC, Clinically suspected oral candidiasis; CSOC, Interquartile range; IQR.
^#Kruskal-Wallis test
^a Statistical difference between the CSOC group and the NOM group
^b Statistical difference between the CSOC group and the non-OPMDs/OC

ISSN: 1472-6831